MedTrace Logo

Probiotics for the Prevention of Major Complications of Cirrhosis

NCT00312910 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2008-05-22

No results posted yet for this study

Summary

The purpose of this study is to determine whether probiotics are effective in the prevention of the complications of liver cirrhosis.

Conditions

Interventions

DRUG

Probiotics-Bio-plus

Sponsors & Collaborators

  • Ambrosia - SupHerb Ltd.

    collaborator INDUSTRY

  • Meir Medical Center

    lead OTHER

Principal Investigators

  • David Pereg, MD · Meir Medical Center, Kfar-Sava, Israel

  • Yona Kitay-Cohen, MD · Meir Medical Center, Kfar-Sava, Israel

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-04-30
Completion
2007-10-31

Countries

  • Israel

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00312910 on ClinicalTrials.gov